Human tumor cells, modified by a novel pressure/crosslinking methodology, promote autologous lymphocyte proliferation and modulate cytokine secretion

Cancer Immunology Immunotherapy

Volumn 46, Issue 6, 1998, Pages 304-310

  Eisenthal, Avi ^a   Goldman, Yechiel ^b   Skornick, Yehuda ^a   Gelfand, Anna ^a   Buyaner, Diana ^c   Kaver, Issac ^a   Yellin, Alon ^d   Yehoshua, Henry ^a   Lifschitz Mercer, Beatriz ^a   Gonnene, Amnon ^c   Shinitzky, Meir ^b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c Immunotherapy Inc   (United States)

^d SHEBA MEDICAL CENTER   (Israel)

Author keywords

Crosslinking; Cytokines; Hydrostatic pressure; Immunotherapy; Tumor vaccine

Indexed keywords

ADENOSINE DIALDEHYDE; GAMMA INTERFERON; INTERLEUKIN 10; MEMBRANE PROTEIN; TUMOR VACCINE;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CELL PROLIFERATION; CELLULAR IMMUNITY; CROSS LINKING; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROSTATIC PRESSURE; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL;

CARCINOMA; CARCINOMA, RENAL CELL; COLONIC NEOPLASMS; CROSS-LINKING REAGENTS; HUMANS; HYPERSENSITIVITY, DELAYED; INTERFERON TYPE II; INTERLEUKIN-10; KIDNEY NEOPLASMS; LEUKOCYTES, MONONUCLEAR; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; PRESSURE; TUMOR CELLS, CULTURED; TUMOR STEM CELLS;

EID: 7344231636     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050491     Document Type: Article

References (35)

1. Baskar S, Ostrand-Rosenberg S, Nabavi N, Nadler LM, Freeman GJ, Glimcher LH (1993) Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules. Proc Natl Acad Sci USA 90:5687-5690
2. Carter LL, Dutton RW (1996) Type 1 and Type 2: a functional dichotomy for all T-cell subsets. Curr Opin Immunol 8:336-342
3. Chen Q, Daniel V, Maher DW, Hersey P (1994) Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma. Int J Cancer 56:755-760
4. Chen YM, Yang WK, Whang-Peng J, Kuo BI, Perng RP (1996) Elevation of interleukin-10 levels in malignant pleural effusion. Chest 110:433-436
5. Clerici M, Shearer GM (1994) The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today 15:575-581
6. Eisenthal A, Ramakrishna V, Skornick Y, Shinitzky M (1993) Induction of cell-mediated immunity against B16-BL6 melanoma in mice vaccinated with cells modified by hydrostatic pressure and chemical crosslinking. Cancer Immunol Immunother 36:300-306
7. Eisenthal A, Skornick Y, Ron I, Zakuth V, Chaitchik S (1993) Phenotypic and functional profile of peripheral blood mononuclear cells isolated from melanoma patients undergoing combined immunotherapy and chemotherapy. Cancer Immunol Immunother 37:367-372
8. Eisenthal A, Matsaev A, Gelfand A, Kahn P, Lifschitz-Mercer B, Skornick Y, Shinitzky M (1996) Surface projection of murine major histocompatibility determinants induced by hydrostatic pressure and cytokines. Pathobiology 64:142-149
9. Fishman MA, Perelson A (1994) Th1/Th2 cross regulation. J Theor Biol 170:25-56
10. Gehan EA (1965) A generalized Wilcoxon test for comparing arbitrary singly-censored samples. Biometrika 52:203-223
11. Hahne M, Rimoldi D, Schöter M, Romero P, Schreier M, French LE, Schneider P, Bornand T, Fontana A, Lienard D, Corotinni JC, Tschopp J (1996) Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science 274:1363-1366
12. Haskin CL, Athanasiou KA, Klebe R, Cameron IL (1993) A heatshock-like response with cytoskeletal disruption occurs following hydrostatic pressure in MG-63 osteosarcoma cells. Biochem Cell Biol 71:361-371
13. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM (1989) Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med 169:59-72
14. Huettner C, Paulus W, Roggendorf W (1994) Increased amounts of IL-10 mRNA in anaplastic astrocytomas and glioblastoma multiforme (Erhöhte Mengen von IL-10 mRNA in anaplastischen Astrozytomen und Glioblastoma Multiformen). Verh Dtsch Ges Pathol 78:418-422
15. Jason J, Sleeper LA, Donfield SM, Murphy J, Warner I, Arkin S, Evatt B (1995) Evidence for a shift from a type I lymphocyte pattern with HIV disease progression. Hemophilia Growth and Development Study. J Acquired Immune Defic Syndr Hum Retrovirol 10:471-476
16. Matsuda M, Salazar F, Petersson M, Masucci G, Hansson J, Pisa P, Zhang QJ, Masucci MG, Kiessling R (1994) Interleukin 10 pretreatment protects target cells from tumor-and-allo-specific cytotoxic T cells and downregulates HLA class I expression. J Exp Med 180:2371-2376
17. Mosmann TR, Sad S (1996) The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17:138-146
18. Pardoll D (1992) New strategies for active immunotherapy with genetically engineered tumor cells. Curr Opin Immunol 4:619-623
19. Pisa P, Halapi E, Pisa EK, Gerdin E, Hising C, Bucht A, Gerdin B, Kiessling R (1992) Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage colony stimulating factor in ovarian cancer biopsies. Proc Natl Acad Sci USA 89:7708-7712
20. Ramakrishna V, Shinitzky M (1991) Potentiation of delayed-type hypersensitivity response to syngeneic tumors in mice prevaccinated with cells modified by hydrostatic pressure and crosslinking. Cancer Immunol Immunother 33:1-8
21. Ramakrishna V, Eisenthal A, Skornick Y, Shinitzky M (1993) Increased projection of MHC and tumor antigens in murine B16-BL6 melanoma induced by hydrostatic pressure and chemical crosslinking. Cancer Immunol Immunother 36:293-299
22. Rapaport FT, Dausset J (1968) Human Transplantation. Grune & Stratton, New York, p 414
23. Roth C, Rochlitz C, Kourilsky P (1994) Immune response against tumors. Adv Immunol 57:281-351
24. Salgame P, Abrams JS, Clayberger C, Goldstein H, Convit J, Modlin RL, Bloom BR (1991) Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254:279-282
25. Shinitzky M, Ramakrishna V, Matsaev A (1997) Hydrostatic pressure, effect on immune system. In: Roitt IM, Delves PJ (eds). Encyclopedia of immunology. Academic Press, New York
26. Smith DR, Kunkel SL, Burdick MD, Wilke CA, Orringer MB, Whyte RI, Strieter RM (1994) Production of interleukin-10 by human bronchogenic carcinoma. Am J Pathol 145:18-25
27. Srivastava PK, Udono H (1994) Heat shock protein-peptide complexes in cancer immonotherapy. Curr Opin Immunol 6:728-732
28. Srivastava PK, Udono H, Blachere NE, Li Z (1994) Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics 39:93-98
29. Strand S, Hofmann WJ, Hug H, Müller M, Otto G, Strand D, Mariani SM, Stremmel W, Krammer PH, Galle, PR (1996) Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - A mechanism of immune evasion? Nat Med 12:1361-1366
30. Suto R, Srivastava PK (1995) A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 269:1585-1588
31. Topalian SL, Solomon D, Avis FP, Chang AE, Freerkson DL, Linehan WM, Lotze MT, Robertson CN, Seipp CA, Simon P, Simpson CG, Rosenberg SA (1988) Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study. J Clin Oncol 6:839-853
32. + T cells by B7-transfected melanoma cells [comments]. Science 259:368-370
33. Wang L, Goillot E, Tepper RI (1994) IL-10 inhibits alloreactive cytotoxic T lymphocyte generation in vivo. Cell Immunol 159:152-169
34. Wang Q, Redovan C, Tubbs R, Olencki T, Klein E, Kudoh S, Finke J, Bukowski RM (1995) Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor-infiltrating lymphocytes. Int J Cancer 61:780-785
35. Welch TJ, Farewell A, Neidhardt FC, Bartlett DH (1993) Stress response of Escherichia coli to elevated hydrostatic pressure. J Bacteriol 175:7170-7177